Corbus Pharmaceuticals Holdings, Inc. (CRBP) Analyst Forecast

NASDAQ Currency in USD Disclaimer

$13.14

north_east $0.14 (1.08%)
Day's range
$12.64
Day's range
$13.4

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
12/02/2024 Piper Sandler Biren Amin $35.00 $17.82   96.41%
10/21/2024 Oppenheimer Jeff Jones $60.00 $18.41   225.91%
09/20/2024 B.Riley Financial Kalpit Patel $40.00 $19.51   105.02%
09/13/2024 Mizuho Securities Graig Suvannavejh $74.00 $51.58   43.47%
08/07/2024 Oppenheimer Jeff Jones $88.00 $48.30   82.19%
07/22/2024 H.C. Wainwright Andres Maldonado $80.00 $58.00   37.93%
06/11/2024 RBC Capital Brian Abrahams $82.00 $43.87   86.92%
06/03/2024 Oppenheimer Jeff Jones $80.00 $42.80   86.92%
05/20/2024 RBC Capital Brian Abrahams $77.00 $45.00   71.11%
03/06/2024 Jefferies Maury Raycroft $46.00 $33.58   36.99%

Corbus Pharmaceuticals Holdings, Inc. FAQ's

What analysts cover Corbus Pharmaceuticals Holdings, Inc.?

Corbus Pharmaceuticals Holdings, Inc. has been rated by research analysts at Piper Sandler, Oppenheimer, B.Riley Financial, Mizuho Securities, H.C. Wainwright, RBC Capital in the past 90 days.